Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Curaleaf Holdings Inc CURLF


Primary Symbol: T.CURA

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.
๏ปฟ

TSX:CURA - Post by User

Comment by blackspade799on Aug 19, 2024 11:48am
63 Views
Post# 36186062

RE:Heads up longs ๐Ÿงจ๐Ÿ’ฃ๐Ÿ’ฃ

RE:Heads up longs ๐Ÿงจ๐Ÿ’ฃ๐Ÿ’ฃ

The public comment period for the proposed rescheduling ended on July 22, with over 43,000 comments submitted. The DEA is currently analyzing these comments, with a final ruling anticipated within the coming weeks.

The proposal to move marijuana to Schedule III was first published by the DEA on May 21, initiating a 60-day public comment period. With that period now concluded, the DEA’s focus has shifted to reviewing every comment, as required by law. According to the DEA official, this process is progressing as planned, despite the volume of comments.

“We’ve already analyzed tens of thousands of comments, but do still have thousands remaining. At this pace, we are still on track for a final rescheduling announcement to come prior to October,” the official stated.

The official requested anonymity, and while we could not independently verify their statements, we did confirm that the individual works for the DEA. This same official accurately informed us in January that the DEA would announce rescheduling before summer (an official announcement came a few months later, on April 30).

If marijuana is moved to Schedule III, it would allow medicines derived from it and its compounds to be prescribed nationwide, pending regulatory approval. The move would also provide state-legal medical marijuana patients and businesses with a range of federal benefits and protections.

Despite the DEA often taking months or even years to analyze comments and reach a final decision on rescheduling proposals, both President Biden and Attorney General Merrick Garland have instructed the agency to expedite the review process.

<< Previous
Bullboard Posts
Next >>